The usefulness of ophthalmoscopy in risk evaluation of hypertensive patients

Blood Pressure

Volumn 11, Issue 5, 2002, Pages 263-269

  Coll de Tuero, Gabriel ^a   Foguet Boreu, Quití ^a   Vargas Vila, Susanna ^a   Saez Zafra, Marc ^a   Barceló Rado, Antonia ^a  

^a Area Basica de Salut Angles ^*  (Spain)

Author keywords

Hypertension; Ophthalmoscopy; Optic fundus; Retinopathy; Risk stratification; Target organ damage

Indexed keywords

CREATININE;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EYE FUNDUS; FEMALE; HUMAN; HYPERTENSION; HYPERTENSION RETINOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OPHTHALMOSCOPY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; TARGET ORGAN; WORLD HEALTH ORGANIZATION;

AGED; AGING; CREATININE; FEMALE; FUNDUS OCULI; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OPHTHALMOSCOPY; REGRESSION ANALYSIS; RISK ASSESSMENT;

EID: 0036432650     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370502320779467     Document Type: Article

References (28)

1. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension. Guidelines for the Management of Hypertension. J Hypertens 11999; 17: 151-83.
2. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-46.
3. Pose Reino A, Gonzalez-Juanatey JR, Castroviejo M, et al. Relación entre hipertrofiaventricular izquierda y la lesión vascular retiniana en la hipertensión arterial ligera. Med Clin (Barc) 1997; 108: 281-5.
4. Daniels SR, Lipman MJ, Burke MJ, Loggie JMH. Determinants of retinal vascular abnormalities in children and adolescents with essential hypertension. J Human Hypertens 1993; 7: 223-8.
5. Schouten EG, Vanderbroucke JP, Van der Heide-Wessl C, Van der Heide RM. Retinopathy as an independent indicator of all causes of mortality. Intern J Epidemiol 1986; 15: 234-6.
6. Gifford RW. The importance of retinal findings in essential hypertension. Bull N Y Acad Med 1969; 45: 922-32.
7. Sokolow M, Perloff D. The prognosis of essential hypertension treated conservatively. Circulation 1961; 23: 697-713.
8. De Leonardis V, Becucci A, De Scalzi M, Cinelli P. Low incidence of cardiac hypertrophy in essential hypertensives with no retinal changes. Int J Cardiol 1992; 35: 95-9.
9. Pontremoli R, Sofia A, Ravera M, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC study. Hypertension 1997; 30: 1135-43.
10. Cerasola G, Cottone S, Mule G, et al. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens 1996; 14: 915-20.
11. Pose Reino A, Gonzalez-Juanatey JR, Pastor C, et al. Clinical implications of white coat hypertension. Blood Press 1996; 5: 264-73.
12. Shigematsu Y, Hamada M, Ohtsuka T, et al. Left ventricular geometry as an independent predictor for extracardiac target organ damage in essential hypertension. Am J Hypertens 1998; 11: 1171-7.
13. Barker LR, Hypertension. In: Barker LR, Burton JR, Zieve PD, editors. Principles of ambulatory medicine, 5th edn. Baltimore: Williams & Wilkins, 1999: 852-4.
14. Kagan A, Aurell E, Dobree JA. Note on signs in the fundus oculi and arterial hypertension: conventional assessment and significance. Bull WHO 1966; 34: 955-60.
15. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1939; 197: 332-43.
16. Klein R, Sharrett R, Klein BEK, et al. Are retinal abnormalities related to atherosclerosis? Arterioscl Thromb Vasc Biol 2000; 20: 1644-50.
17. Dimmit SB, Eames SM, Gosling P, West JNW, Gibson JM, Littler WA. Usefulness of ofthalmoscopy in mild to moderate hypertension. Lancet 1989; 1: 1103-6.
18. Ogden LG, HE J, Lydick E, Whelton PK. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 2000; 35: 539-43.
19. Klein R, Klein BEK, Moss SE. The relation of systemic hypertension to changes in the retinal vasculature. The Beaver Dam Eye Study. Trans Am Ophth Soc 1997; 95: 320-48.
20. Dalfó A, Lopez-Contreras J, Gil M, et al. Electrocardiographic diagnostic of left ventricular hypertrophy (LVH). Proposal of modification of Cornell criteria. Am J Hypertens 1997; 10: 206A.
21. Dodson PM, Lip GYH, Eames SM, Gibson JM, Beevers DG. Hypertensive retinopathy: a review of existing classification systems and a suggestion for a simplified grading system. J Human Hypertens 1996; 10: 93-8.
22. Van Buchem FSP, Heuvel-Aghina JWMTh, Heuvel JEA. Hypertension and changes of the fundus oculi. Acta Med Scand 1964; 176: 539-48.
23. Cugini P, Cruciani F, Turri M, et al. Minimal-change hypertensive retinopathy and arterial pre-hypertension, illustrated via ambulatory blood-pressure monitoring in putatively normotensive subjects. Int Ophtalmology 1999; 22: 145-9.
24. Bock KD. Regression of retinal vascular changes by antihypertensive therapy. Hypertension 1984; 6 Suppl III: III-158-III-162.
25. Perneger TV, Nieto FJ, Whelton PK, Klag MJ, Comstock GW, Szklo M. A prospective study of blood pressure and serum creatinine. Results from the "Clue" Study and the ARIC Study. JAMA 1993; 269: 488-93.
26. Houben AJHM, Canoy MCW, Paling HA, Derhaag PJFM and de Leeuw PW. Quantitative analysis of retinal vascular changes in essential and renovascular hypertension. J Hypertens 1995; 13: 1729-33.
27. Hubbard LD, Brothers RJ, King WN, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophtalmology 1999; 106: 2269-80.
28. Enström I, Burtscher IM, Eskilsson J, et al. Organ damage in treated middle-aged hypertensives compared to normotensives: results from a cross-sectional study in general practice. Blood Press 2000; 9: 28-33.